IMAI Medtech provides technology for 3D histology, focusing on improving the speed and accuracy of tissue processing and cancer diagnosis. The company's methods reduce preparation time and enhance diagnostic capabilities.

IMAI Medtech

Abbott develops and delivers health care technologies and products. The company focuses on various sectors of health care, including diagnostics and nutrition. Self-described as a provider of life-changing solutions.

Abbott

Cancer Diagnostics, Inc. provides medical tissue marking dyes and equipment for histology and cytology applications. It is ISO 13485 Accredited and FDA cGMP Compliant.

Cancer Diagnostics, Inc.

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.

James Wood Johnson

Edward Mead Johnson

Robert Wood Johnson

Johnson & Johnson

IMAI MedTech | 565 followers on LinkedIn. Adding the 3rd dimension to the detection of cancer | IMAI is committed to improving cancer diagnostics by specializing in a rapid and automated tissue preparation approach, including digital tissue visualization of biopsies. IMAI strives to bring about a groundbreaking change in histology. The solution developed by IMAI avoids the time-consuming manual cutting of tissue into micrometer-thin slices.

Data Science | Project Management

Rebecca Gergess

Software Development & Image Analysis at IMAI MedTech

Beda R.

Co-founder of IMAI MedTech | Dr. sc. ETH Zurich

Robert Axelrod

Project Manager @Autonomous River Cleanup | Semester Project @IMAI MedTech

Oscar Gentilhomme

IMAI MedTech

It was a pleasure to present IMAI MedTech at the Clinical Translation Oncology from UMC Utrecht event held at the impressive Military Museum. Many thanks to Kyah van Megesen and the rest of the team for the excellent organization and kind invitation! I truly enjoyed the insightful conversations with participants and felt inspired by the brilliant talks from other speakers! Francesca Catto

We are excited to start the week off by pitching at the University of St.Gallen ! Great opportunity to participate as a case study in the CFO-challenge here. Thanks for this great initiative. Great organization by Julian Mordig and team. We are very much looking forward to the project pitches of the master's students this Wednesday! #3Dhistology #IMAI #CFOchallenge #HSG

It was extremely stimulating to talk about the future of 3D histology with the future generation of medical doctors. IMAI was at the Swiss Medical Students' Convention (SMSC) in Basel this weekend. Martina Cerisoli , Beda R. , Orazio Angelo Arcidiacono, Ph.D. , and Mascha Pfyl presented, discussed, demonstrated, and inspired at the SMSC Basel 2024! Thanks a lot to the organizers and we are really excited to be part of the community that is pioneering the future of medicine! #3Dhistology #SMSC #futureofmedicine #IMAI

Some impressions from Launch 2024, an event by ETH Entrepreneur Club and SICTIC that brings together #startups , investors, and students. The Health and Medtech industry was well represented in the exhibition by startups like IMAI MedTech , Citus , UpLeap (by breathe medical) , OrthoSens , and many more. Health Innovation Hub Aargau is excited about these startups driving #innovation and taking the Medtech industry to the next level. Soon a startup hub will be opened on ETH premises at Kantonsspital Baden AG Baden (KSB), offering office space and easy connections to the #clinic . Interested startups are welcome to get in touch! Bettina Thumm David Sachs Thomas Lumpe Iwan Haechler Solabs Nanotechnology Robert Axelrod Estelle Clerc Marjan Kraak

Health Innovation Hub Aargau

See you tomorrow at Launch 2024! We'll be exhibiting at BOOTH 27 in the NO building at ETH Zurich. Pass by to learn more about how IMAI MedTech is adding the 3rd dimension to the analysis of tissue samples. #3Dhistology #Entrepreneurship #ETH

Curious to see which industries will be represented in Launch 2024? Slide and meet our diverse group of 40+ exhibiting startups! Join us at ETH Zurich on October 18th and experience this impressive concentration of innovative technologies. Students and ETH members, secure your free tickets here!! 🔗 https://lnkd.in/ePreQK7S Swiss-Mile , apheros , Floating Robotics , bottleplus , DPhi Space , ANYbotics , IMAI MedTech , irmos technologies AG , qCella , CompagOs , GoNiña , DeepPSY AG , BCHAR , Borobotics GmbH , UpLeap (by breathe medical) , Solskin by Zurich Soft Robotics , Riverkin , Conda.ch , Kolbev , Artifact , CellX Biosolutions , Firefly Fusion , AtlasVR Ltd , House of Charts , Winduction AG , Invariant Labs , Citus , Niatsu , RoBoa , NoMaze , Skaaltec , Manukai AG , Ionic Wind Technologies , Hoshī , Anevo , optohive , Solabs Nanotechnology Newbridge SA , Zupan , nunu.ai

ETH Entrepreneur Club

What is the most promising ETH Zürich invention of 2024? Join us at the ETH Industry Day where we unveil the winner of the Spark Award: https://lnkd.in/dPEhQPS One of the finalists revolutionises cancer diagnosis with quick and comprehensive 3D pictures of biopsy tissue samples: https://lnkd.in/etrkGGgn Robert Axelrod , Jana Bünder , Stephan Cecil Fox , Alexander Mathys , Mirko Meboldt , Adriano Aguzzi , Francesca Catto , IMAI MedTech , Leandro Buchmann

ETH Zurich Industry Relations

I am honored to be named Entrepreneur of the Month for September by TechLounges! This recognition reflects the dedication of the IMAI MedTech team as we advance tissue research and diagnostics with our 3D histology platform. Thank you to everyone supporting us on this journey! 👉 Check out the article for a quick dive into our story! #EntrepreneurOfTheMonth #IMAI #Innovation #MedTech #Startup IMAI MedTech Robert Axelrod Sascha Brun

Francesca Catto

Excited to pitch at the MEDKAP Investors Pitch Event on October 1st! Thank you, MEDKAP Investor Association and Vincent Irrling , for the invitation – looking forward to it!

Meet the exhibiting startups for Launch 2024! 🚀 On October 18th at ETH Zürich , we along with SICTIC will host one of the biggest innovation and technology showcase in Switzerland as 40+ startups take center stage. Many exciting developments will follow as we gear up for an electrifying Launch, we are just getting started! Get your tickets for Launch 2024 and don't miss out on the action! 🔗 https://lnkd.in/ePreQK7S Swiss-Mile , apheros , Floating Robotics , bottleplus , DPhi Space , ANYbotics , IMAI MedTech , irmos technologies AG , qCella , CompagOs , GoNiña , DeepPSY AG , BCHAR , Borobotics GmbH , breathe medical , Solskin by Zurich Soft Robotics , Riverkin , Conda.ch , Kolbev , Artifact , CellX Biosolutions , Firefly Fusion , AtlasVR Ltd , House of Charts , Winduction AG , Invariant Labs , Citus , Niatsu , RoBoa , NoMaze , Skaaltec , Manukai AG , Ionic Wind Technologies , Hoshī , Anevo , optohive , Solabs Nanotechnology , Newbridge SA

Metric
Company Name	IMAI Medtech	Abbott	Cancer Diagnostics, Inc.	Johnson & Johnson
Symbol				JNJ
MSH ID	COM:IMAI-MEDTECH	COM:ABBOTT	COM:CANCERDIAGNOSTICS	COM:JNJ
Market	PRIVATE	PRIVATE	PRIVATE	STOCKS
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services	Healthcare
Industry	Medical Technology	Medical Devices and Diagnostics	Medical Devices	Drug Manufacturers - General
Country	CH	US	US	US
Stage
Employee Count		10.00K		131.90K
Website	imai-medtech.com	abbott.com	cancerdiagnostics.com	jnj.com
LinkedIn	imai-medtech		cancer-diagnostics-inc	johnson-&-johnson
Founders

Metric
Market Cap			359.63B
Enterprise Value
Monthly Web Traffic	873.36K	4.98K	2.26M
Web Traffic Growth	-0.14	1.87	0.02
Valuation
Raised Capital

Metric
Revenue				85.15B
Revenue (LTM)
Revenue (NTM)
Gross Profit				58.41B
EBITDA				29.34B
Operating Income				21.85B
Net Income				14.17B
EPS				5.59
Diluted EPS				5.53
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin				0.71
Operating Profit Margin				0.30
EBITDA Margin				0.34
Net Profit Margin				0.45
Return on Equity				0.57
Return on Assets				0.24
Return on Capital Employed				0.21

COM:IMAI-MEDTECH

IMAI Medtech

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio				10.85
P/B Ratio				5.27
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio				4.66
EV Multiple				13.83

Metric
Days Sales Outstanding				56.66
Days Payables Outstanding				98.44
Days Inventory Outstanding				178.66
Operating Cycle				245.26
Cash Conversion Cycle				115.35
Asset Turnover				0.56

Metric
Operating Cash Flow				22.79B
Free Cash Flow				18.25B
Cash Flow to Debt				0.78
Operating Cash Flow/Sales				0.28
Free Cash Flow Yield				0.04

Metric
Cash & Equivalents				21.86B
Accounts Receivable				-624M
Inventory				11.18B
Goodwill				36.56B
Debt to Capitalization				0.37
Debt to Assets				0.18
Current Ratio				1.21
Quick Ratio				0.94

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue				0.01
R&D to Revenue				0.16
SG&A to Revenue				0.06